Dr Lal PathLabs set to launch its IPO soon

30 Nov 2015 Evaluate

Leading diagnostic chain Dr Lal PathLabs is all set to launch its initial public offering (IPO) soon. The company has already received Securities and Exchange Board of India’s (SEBI) approval for the same.

The company had filed its Draft Red Herring Prospectus (DRHP) with SEBI in September for the IPO wherein the promoters and other existing shareholders will collectively sell 1.16 crore shares of the company. The main promoter group plans to divest five percent, while other investors such as Wagner and Westbridge Crossover Fund will divest 9.1 percent stake.

Dr Lal PathLabs is a pioneer diagnostic centre in India that provides blood test services. It is believed to be the most trusted pathology lab in the country.

Dr. Lal Pathlabs Share Price

2953.35 -67.15 (-2.22%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7248.75
Max Healthcare Inst 1166.60
Narayana Hrudayalay 1286.30
Aster DM Healthcare 486.85
Global Health 1098.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.